FindTrial
Sign In

Efficacy of Rasonadi Churna on Hyperandrogenism in PCOS affecting menstrual irregularities.

Randomized controlled clinical trial to study the efficacy of Rasonadi Churna on Hyperandrogenism in PCOS affecting menstrual irregularities. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067094
Enrollment
150
Registered
2024-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Rekha Chhagan Kuwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married and Unmarried patients of PCOS with Rotterdam criteria.

Exclusion criteria

Exclusion criteria: Patients having - Hypogonadotrophic hypogonadism. - Premature ovarian failure. - Congenital adrenal hyperplasia. - Hyperprolactenemia. - Thyroid abnormalities. - Tuberculosis. - Congenital anomalies.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Rasonadi Churna in terms of irregular interval of menstrual periods.Timepoint: 12 Weeks—

Secondary

MeasureTime frame
- To study the effect of Rasonadi Churna on hyperandrogenesim. - To study the effect of Rasonadi Churna on hyperandrogenesim and insulin resistance.Timepoint: 12 Weeks—

Countries

India

Contacts

Public ContactDr Manoj V Gaikwad

R A Podar Ayuverdic Medical College

drmanojvgaikwad@gmail.com9822752816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026